top of page

H.C. Wainwright & Co. CEO Mark Kaplan sees a warming up of the fundraising environment for biotech over the coming months

  • blonca9
  • 2 days ago
  • 1 min read

Kicking off BiotechTV's coverage of the 2025 HCW Global Investor Conference in New York, the new CEO of H.C. Wainwright gives his take on the sector and previews the conference.




Coverage brought to you by:

ree

Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Genezen_Logo_RGB.png

Genezen is a contract development and manufacturing organization (CDMO) with unique technical expertise in lentiviral, retroviral, and adeno-associated viral vectors. Offering process development, GMP viral vector manufacturing, and analytics, we are dedicated to helping you deliver safe, pure, and potent advanced therapies to the patients who need them.

bottom of page